1. Home
  2. TDOC vs NEO Comparison

TDOC vs NEO Comparison

Compare TDOC & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teladoc Health Inc.

TDOC

Teladoc Health Inc.

HOLD

Current Price

$6.60

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.24

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDOC
NEO
Founded
2002
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2015
2008

Fundamental Metrics

Financial Performance
Metric
TDOC
NEO
Price
$6.60
$9.24
Analyst Decision
Buy
Strong Buy
Analyst Count
18
8
Target Price
$7.56
$13.38
AVG Volume (30 Days)
4.7M
2.0M
Earning Date
04-29-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
80.58
N/A
EPS
N/A
N/A
Revenue
$2,406,840,000.00
N/A
Revenue This Year
$1.19
$10.63
Revenue Next Year
$1.25
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
18.41
N/A
52 Week Low
$4.40
$4.72
52 Week High
$9.77
$13.74

Technical Indicators

Market Signals
Indicator
TDOC
NEO
Relative Strength Index (RSI) 56.48 60.46
Support Level $6.42 $7.42
Resistance Level $7.95 $10.82
Average True Range (ATR) 0.32 0.40
MACD -0.06 0.04
Stochastic Oscillator 28.76 89.45

Price Performance

Historical Comparison
TDOC
NEO

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: